VALORIZATION
In this addendum, I outline the valorization opportunities for the empirical studies presented in this dissertation, including the managerial and economic relevance of the research topics, the innovativeness of the research findings, and their value for firm innovation and practices in management.
As explained in the introductory chapter, the main purpose of this dissertation is to develop a better understanding of the inter-relation between M&As and innovation, paying a particular attention to the antecedents and consequences of M&As. On the one hand, innovation has increasingly become an important way for firms to obtain and maintain a competitive advantage and to achieve a higher performance in the long run (Cassiman and Colombo, 2006; Conner, 1991; Hitt et al., 1997; Teece et al., 1997) . On the other hand, M&As have become a popular strategy to access new knowledge, capabilities and technology assets, and know-how held by the acquisition target (Arora, Fosfuri & Gambardella, 2001; Capron, Dussauge & Mitchell, 1998; Cassiman, Colombo, Garrone & Veugelers, 2005; Granstrand & Sjolander, 1990; Graebner, 2004) .
Nevertheless, despite the potential benefits M&As provide access to, a set of mixed innovation and performance results have been found. M&As studies report both positive and negative effects, but with a large body of literature documenting a negative impact of M&As on corporate innovation (e.g. Cassiman et al., 2005; Prichett, 1985; Ravenscraft and Scherer, 1987; see Veugelers, 2006 , for a survey of the literature). These fragmented findings suggest that M&As are still not very well understood and that scholars still know very little about what makes M&As succeed or fail (Bower, 2001; Hoskisson et al., 1991; Jemison and Sitkin, 1986; Schweizer, 2005) . Trying to add to this discussion, three research questions have been explored in this dissertation.
The first empirical study in this dissertation explores a mechanism by which firms can counteract the post-M&A negative effects on innovation. This study makes use of the literature that illustrates the importance of the transferability of knowledge across and within firms through individual talents (Kim, 1997; Song et al., 2003; Zander and Kogut, 1995) to explore the potential role that key inventors play in knowledge transfer in periods of reorganization and that can mitigate Finally, the fourth chapter of this dissertation examines an innovation mechanism that motivates pharmaceutical firms' decision to engage in M&As. In particular, this paper studies the impact that the expiration of patents, as a technological source of competitive advantage, has on firms' decision to engage in acquisition activities. Previous literature has pointed the need for an adequate empirical research on acquisitions that deepens on the motives, industry sector and firm characteristics to understand the performance outcomes of acquisitions and the high failure rates (Bower, 2001; Pablo and Javidan, 2004; Schweizer, 2005; Sirower, 1997) .
The empirical analysis from this study suggests that patent expiration is a triggering factor in firms' acquisition decision. This indicates that pharmaceutical firms resort to acquisitions when they need to fill the pipeline gaps left by expiring patents and to maintain revenue streams. The empirical results also show that innovative capability negatively moderates this effect. In particular, for pharmaceutical firms that possess a large basic research base and that have higher levels of R&D efforts, the effect of patent expiration on the decision to engage in acquisitions is not as pronounced. From a managerial point of view, the paper stresses the importance of innovation indicators as anticipating factors of acquisition activity. Moreover, this last chapter suggests that managers should pay attention to and plan for long-term innovation strategies. A clever patent portfolio management and strategic timing of patent applications, as well as strong internal research capabilities, can avoid depletion on firms' patent portfolio and the associated disruptions in the pharmaceutical pipelines.
Overall, the studies presented in this dissertation as particularly useful for managers and policy makers, especially those dealing with innovation intensive industries or firms. As mentioned above, in the recent decades, firms' competitiveness has increasingly become dependent on its ability to keep up with innovative products and processes, and R&D activities, which stimulate innovation and improve firms' absorptive capacity. R&D activities lead to the creation of new technologies that can be used to develop new products that satisfy consumers' needs and market demand, or to develop new processes that lower the production costs, increasing market share, sales and profits. However, while firms' main innovation input comes from internal R&D activities, the increasing complexity of research, as well as the fast pace of technological change, technological and non-technological firms, rely on knowledge external to the firm obtained, among others, through M&As. The increasing importance of M&As has been reflected in the number and value of M&As transactions in the last couple of years with over 13,000 transactions representing over $1.700 trillion in 2016 (S&P Global Market Intelligence, 2017) . Thus research on the relation of M&As and innovation represents an important venue for managers and policy makers to understand the factors that affect performance outcomes of acquisitions and the high failure rates. I hope that the studies presented in this dissertation shed some light in this direction.
